Assignee
AAVNERGENE INC
US·2 granted patents·2 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0169US12583907B2Modified plasma clotting factor VIII and method of use thereofAAVNERGENE INC·Filed 2023·Granted Mar 24, 2026·0 cites·17 claims
- 0258US2024229067A9Compositions and methods for recombinant parvovirus productionAAVNERGENE INC·Filed 2023·Application pending·0 cites
- 0356US2023365991A1Compositions and methods for recombinant parvovirus productionAAVNERGENE INC·Filed 2023·Application pending·0 cites
- 0455US11795207B2Modified plasma clotting factor VIII and method of use thereofAAVNERGENE INC·Filed 2021·Granted Oct 24, 2023·0 cites·26 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →